Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HLA complex group 14 (HCG14) is a long non-coding RNA (lncRNA) gene located in the major histocompatibility complex (MHC) region on chromosome 6. It is not a classical protein-coding therapeutic target such as a receptor or enzyme, but instead functions as a non-coding RNA involved in genetic regulation. Recent research shows HCG14 is associated with celiac disease, acting independently of classical HLA-DR-DQ risk loci. HCG14 appears to regulate the expression of NOD1 in intestinal epithelial cells and may contribute to disease predisposition through this regulatory activity[1][2][3][4][5][9][10].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on HLA complex group 14 (non-protein coding) (HCG14).